v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   6,525,887      
Beginning balance at Dec. 31, 2024 $ 169,436 $ 0 $ 824,780 $ (228) $ (655,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   33,040      
Issuance of common stock upon exercise of stock options 404   404    
Stock-based compensation 3,495   3,495    
Net loss (28,200)       (28,200)
Other comprehensive income (loss) (223)     (223)  
Ending balance (in shares) at Mar. 31, 2025   6,558,927      
Ending balance at Mar. 31, 2025 144,912 $ 0 828,679 (451) (683,316)
Beginning balance (in shares) at Dec. 31, 2024   6,525,887      
Beginning balance at Dec. 31, 2024 169,436 $ 0 824,780 (228) (655,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (49,594)        
Ending balance (in shares) at Jun. 30, 2025   6,750,716      
Ending balance at Jun. 30, 2025 131,670 $ 0 837,185 (805) (704,710)
Beginning balance (in shares) at Mar. 31, 2025   6,558,927      
Beginning balance at Mar. 31, 2025 144,912 $ 0 828,679 (451) (683,316)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   5,952      
Issuance of common stock upon exercise of stock options 71   71    
Issuance of common stock in at-the-market offering, net of issuance costs (in shares)   185,837      
Issuance of common stock in at-the-market offering, net of issuance costs 6,611   6,611    
Stock-based compensation 1,824   1,824    
Net loss (21,394)       (21,394)
Other comprehensive income (loss) (354)     (354)  
Ending balance (in shares) at Jun. 30, 2025   6,750,716      
Ending balance at Jun. 30, 2025 $ 131,670 $ 0 837,185 (805) (704,710)
Beginning balance (in shares) at Dec. 31, 2025 6,781,976 6,781,976      
Beginning balance at Dec. 31, 2025 $ 113,866 $ 0 840,937 (583) (726,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 985   985    
Net loss (4,204)       (4,204)
Other comprehensive income (loss) 51     51  
Ending balance (in shares) at Mar. 31, 2026   6,781,976      
Ending balance at Mar. 31, 2026 $ 110,698 $ 0 841,922 (532) (730,692)
Beginning balance (in shares) at Dec. 31, 2025 6,781,976 6,781,976      
Beginning balance at Dec. 31, 2025 $ 113,866 $ 0 840,937 (583) (726,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (8,503)        
Ending balance (in shares) at Jun. 30, 2026 6,781,976 6,781,976      
Ending balance at Jun. 30, 2026 $ 107,380 $ 0 842,958 (587) (734,991)
Beginning balance (in shares) at Mar. 31, 2026   6,781,976      
Beginning balance at Mar. 31, 2026 110,698 $ 0 841,922 (532) (730,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,036   1,036    
Net loss (4,299)       (4,299)
Other comprehensive income (loss) $ (55)     (55)  
Ending balance (in shares) at Jun. 30, 2026 6,781,976 6,781,976      
Ending balance at Jun. 30, 2026 $ 107,380 $ 0 $ 842,958 $ (587) $ (734,991)